Skip to main content
56 results

Originally presented at the PCRS Respiratory Conference 2020 Frances Barrett presents on "How to assess the acutely breathless patient - making sure we don't miss anything"

Point-of-care testing of C-reactive protein (CRP) for the acute assessment of worsening symptoms in people known to have COPD can safely reduce the use of antibiotics and could help improve the diagnostic approach towards someone presenting in such a crisis.

For over a year many medical tests, including spirometry, have been put on hold due to the COVID-19 pandemic.  

NCSCT and Public Helth England have announced the resumption of face-to-face stop smoking consultations and carbon monoxide (CO) monitoring. CO monitoring is a valuable motivational tool for smokers.

PCRS has produced a new position statement on spirometry.  In the statement we discuss who should undertake and interpret spirometry and when it should be undertaken, specifically in light in COVID-19 restrictions.  The statement also references primary care network diagnostic hubs.

Spirometry, a test used to measure and monitor lung function, is an important component of the diagnosis, management and monitoring of respiratory conditions in primary care.

Peak flow charting and microspirometry are undervalued in guidelines and were underused in primary care even before the COVID pandemic, but have enhanced importance now given the difficulties with access to more formal respiratory function testing.

This short FAQ helps to answer some of your questions regarding spirometry in primary care during the COVID-19 pandemic.  For further information please visit the ARTP website.

Greener respiratory healthcare puts patients at the heart of the system Holistic care that puts patients at the heart of systems and decision-making processes so that they are more likely to adhere to appointments, self-care and prescribed medicines is key to achieving greener respirato

Guidance was published in April 2021 regarding the reinstatement of spirometry services during and post-COVID-19.

Patients with respiratory symptoms and disease deserve a correct diagnosis and correct guideline driven care that is standardized, patient focused, delivered by a Health Care Professional (HCP) with suitable training and experience, at a site and within an appropriate timeframe to meet their need

Alongside a detailed clinical history and other important tests to assess variability (peak flow, reversibility and challenge tests) it is used to support the diagnosis of asthma. PCRS has produced this consensus position on the use of FeNO in primary care to support the diagnosis of as